NCT04356638View on ClinicalTrials.gov

a Phase III Trial of Safety and Efficacy of Premedication With Dexmedetomidine and Midazolam in Pediatric Patients

PHASE3RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

October 17, 2021

Primary Completion Date

December 30, 2023

Study Completion Date

December 30, 2023

Conditions
Anxiety StatePerioperative/Postoperative Complications
Interventions
DRUG

Midazolam

Oral Midazolam and intranasal placebo

DRUG

Dexmedetomidine

Intranasal Dexmedetomidine and oral placebo

OTHER

Placebo

Placebo orally and intranasally

Trial Locations (1)

Unknown

RECRUITING

King Faisal Specialist Hospital & Research Center, Riyadh

All Listed Sponsors
lead

King Faisal Specialist Hospital & Research Center

OTHER